Answer
In adults receiving only Invanz (ertapenem) in clinical studies, the most common adverse reactions during treatment and the 14 days after stopping were diarrhoea (4.8%), infused vein complication (4.5%) and nausea (2.8%).
Sources for this answer
- INVANZ 1g powder for concentrate for solution for infusionMerck Sharp & Dohme (UK) Limited · emc · SmPC §4.8 Undesirable effects · Version 28Document updated
Sources checked